Top 5 Stocks Billionaire David Einhorn Just Added to His Portfolio

Below we present the list of the top 5 stocks billionaire David Einhorn just added to his portfolio. For background on the billionaire money manager, a look at some of his other recent stock purchases, as well as our methodology, please see Top 10 Stocks Billionaire David Einhorn Just Added to His Portfolio.

5. Galapagos NV (NASDAQ:GLPG)

Value of Greenlight Capital’s 13F Position: $10.2 million

Number of Hedge Fund Shareholders: 27

Hedge funds are finding Galapagos NV (NASDAQ:GLPG) increasingly intriguing as ownership of GLPG among top money managers more than doubled in 2021 even as the shares lost 47% of their value. David Einhorn was one of those money managers trying to buy low on GLPG in Q4, as he bought 185,000 shares of the stock.

Galapagos NV (NASDAQ:GLPG) shares have performed better so far in 2022, gaining nearly 14%. Those gains primarily came in late January, when the company announced that former Johnson & Johnson (NYSE:JNJ) chief scientific officer Paul Stoffels would take over as Galapagos’ CEO beginning on April 1.

Galapagos NV (NASDAQ:GLPG) shares have been done in over the past two years due in part to two of the most advanced and promising drugs in its pipeline failing to receive FDA approval. The first was oral rheumatoid arthritis drug Filgotinib, which was anticipated to reach $4 billion in annual sales at its peak. The drug has been approved in the EU and Japan. Next up was idiopathic pulmonary fibrosis treatment ziritaxestat, which while effective, was deemed to have an unfavorable safety-to-benefit ratio.